Ensho Therapeutics
Ensho Therapeutics is a startup headquartered in Woodcliff Lake, United States, founded in 2024. It has raised at least $27.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Ensho Therapeutics has raised at least $27.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Ensho Therapeutics sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Related
Questions and answers
What does Ensho Therapeutics do?
Ensho Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Ensho Therapeutics raised?
At least $27.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Ensho Therapeutics based?
Ensho Therapeutics is headquartered in Woodcliff Lake, United States.
When was Ensho Therapeutics founded?
Ensho Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.